Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Genzyme Transgenics to develop monoclonal antibodies for Centocor

Dec. 11, 1998

Zeneca and Amersham Pharmacia Biotech will collaborate on proteomics research

Dec. 11, 1998

Two NIH grants awarded to Atrix for preclinical studies on Atrigel polymer system

Dec. 11, 1998

CIMA reports significant transmucosal absorption-enhancing effects for OraVescent

Dec. 9, 1998

Major R&D agreement signed by two German companies

Dec. 8, 1998

CuraGen, Glaxo Wellcome initiate collaborative pharmacogenomics-based drug discovery effort

Dec. 7, 1998

Atrix acquires ViroTex and expands drug delivery technology base

Dec. 4, 1998

Isis sublicenses technology for designing improved antisense drugs

Dec. 2, 1998

Novel injectable drug delivery technology in-licensed by Medi-Ject

Dec. 2, 1998

Jenner Biotherapies receives patent on improved vaccine formulation

Dec. 1, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...